Organization Overview
Alternative names
atezolizumab (Tecentriq) (1 trial)
bevacizumab (avastin) (1 trial)
cabozantinib (cometriq) (1 trial)
Adenocarcinoma (Phase 2)
Ankle Fractures (Phase 2)
Anorexia (Phase 2)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Biliary Tract Diseases (Phase 2)
Bipolar Disorder (Phase 4)
Cachexia (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Cardiovascular Diseases (Phase 4)
Cerebral Infarction (Phase 4)
Colonic Diseases (Phase 2)
Communicable Diseases (Phase 2)
Delirium (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Fatigue (Phase 3)
Fractures, Bone (Phase 2)
Gastrointestinal Hemorrhage (Phase 4)
Hemorrhage (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Herpes Labialis (Phase 2)
Herpes Simplex (Phase 2)
Hot Flashes (Phase 2)
Infections (Phase 4)
Ischemia (Phase 4)
Liver Neoplasms (Phase 4)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Mouth Neoplasms (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Peptic Ulcer (Phase 4)
Peptic Ulcer Hemorrhage (Phase 4)
Peripheral Arterial Disease (Phase 4)
Peripheral Vascular Diseases (Phase 4)
Pneumonia (Phase 2)
Proteinuria (Phase 4)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Rectal Neoplasms (Phase 2)
Shock (Phase 2)
Shock, Septic (Phase 2)
Stroke (Phase 4)
Surgical Wound Infection (Phase 4)
Thrombosis (Phase 4)
Weight Loss (Phase 2)